Revvity's stock underperformed the S&P 500 on August 18, 2025.
4 reports, 2 independent
Updated Aug 18
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Revvity's stock underperformed the S&P 500 on August 18, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Revvity stock underperformed the S&P 500 on August 18, 2025.1 source
Revvity stock outperformed the S&P 500 in July 2025.1 source
Keep exploring
The entities involved
-
Revvity
American biotech company
Related events
Coverage
Newest first; wire copies grouped- StockStory3 Reasons to Sell RVTY and 1 Stock to Buy Instead Over the past six months, Revvity’s stock price fell to $90.78. Shareholders have lost 18.8% of their capital, which is disappointing considering the
- ZacksRevvity (RVTY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates For the quarter ended June 2025, Revvity (RVTY) reported revenue of $720.28 million, up 4.1% over the same period last yea
- ZacksWall Street's Insights Into Key Metrics Ahead of Revvity (RVTY) Q2 Earnings Wall Street analysts expect Revvity (RVTY) to post quarterly earnings of $1.14 per share in its upcoming report, which indi
- StockStory3 Reasons to Sell RVTY and 1 Stock to Buy Instead Over the past six months, Revvity’s stock price fell to $102.40. Shareholders have lost 16.5% of their capital, which is disappointing considering th